Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-26 Option Award | 2025-06-26 5:47 pm | N/A 2035-06-25 | Contineum Therapeutics Inc. | CTNM | Schimmelpennink Evert B. Director | 14,750 | $0 | 14,750 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 6:10 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 4,200 | $1.04 | 387,106 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-07 6:10 pm | N/A 2031-03-07 | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 4,200 | $0 | 387,106 (Direct) | View |
| 2025-01-09 Option Award | 2025-01-13 5:20 pm | N/A 2035-01-08 | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 279,100 | $0 | 279,100 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:33 pm | N/A 2034-11-20 | iBio Inc. | IBIO | Schimmelpennink Evert B. Director | 18,900 | $0 | 18,900 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 8:16 pm | N/A N/A | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 45,000 | $1.04 | 387,106 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 8:16 pm | N/A 2031-03-07 | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 45,000 | $0 | 387,106 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 5:53 pm | N/A 2034-05-23 | Contineum Therapeutics Inc. | CTNM | Schimmelpennink Evert B. Director | 29,500 | $0 | 29,500 (Direct) | View |
Ownership | 2024-04-04 5:59 pm | N/A 2032-01-17 | Contineum Therapeutics Inc. | CTNM | Schimmelpennink Evert B. Director | 0 | $0 | 32,090 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-25 8:32 pm | N/A 2031-03-07 | LENZ Therapeutics Inc. | LENZ | Schimmelpennink Evert B. President, CEO and Secretary | 1,260,693 | $0 | 1,260,693 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-13 7:09 pm | 2022-01-09 2031-12-08 | iBio Inc. | IBIO | Schimmelpennink Evert B. Director | 109,000 | $0 | 109,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-09 5:19 pm | 2021-07-07 2031-06-06 | iBio Inc. | IBIO | Schimmelpennink Evert B. Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-10-01 Equity Swap | 2020-10-05 8:30 pm | N/A 2027-09-01 | Pfenex Inc. | PFNX | Schimmelpennink Evert B. See Remarks | 1,096,720 | $0 | 0 (Direct) | View |